| scholarly article | Q13442814 |
| P50 | author | Jeniel E Nett | Q89481229 |
| P2093 | author name string | Jeniel E Nett | |
| P2860 | cites work | Development of an in vitro model for the multi-parametric quantification of the cellular interactions between Candida yeasts and phagocytes | Q27308045 |
| Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms | Q28302942 | ||
| The Extracellular Matrix of Candida albicans Biofilms Impairs Formation of Neutrophil Extracellular Traps | Q28554057 | ||
| Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species | Q28829671 | ||
| Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital | Q33401940 | ||
| Use of RNA-Protein Complexes for Genome Editing in Non-albicans Candida Species | Q33823090 | ||
| Immunity to Candida | Q34143094 | ||
| First three reported cases of nosocomial fungemia caused by Candida auris | Q34196357 | ||
| Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris | Q34492906 | ||
| First hospital outbreak of the globally emerging Candida auris in a European hospital | Q34543358 | ||
| Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses | Q34547546 | ||
| Candida albicans biofilms do not trigger reactive oxygen species and evade neutrophil killing | Q36412239 | ||
| Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel | Q37664411 | ||
| Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Healthcare Surface | Q38659451 | ||
| Candida auris candidaemia in Indian ICUs: analysis of risk factors | Q38883902 | ||
| The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation. | Q38949297 | ||
| Hog1 Regulates Stress Tolerance and Virulence in the Emerging Fungal Pathogen Candida auris | Q57793431 | ||
| Emerging Fungal Pathogen Candida auris Evades Neutrophil Attack | Q58730092 | ||
| Candida auris in Healthcare Facilities, New York, USA, 2013-2017 | Q58794314 | ||
| Filamentation in Candida auris, an emerging fungal pathogen of humans: passage through the mammalian body induces a heritable phenotypic switch | Q59804393 | ||
| First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia | Q39092138 | ||
| Multidrug-resistant endemic clonal strain of Candida auris in India. | Q39092162 | ||
| Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris. | Q39092336 | ||
| Mechanisms involved in the triggering of neutrophil extracellular traps (NETs) by Candida glabrata during planktonic and biofilm growth | Q42376003 | ||
| Candida auris-associated candidemia, South Africa | Q42712931 | ||
| Candida auris candidemia in Kuwait, 2014. | Q42787996 | ||
| Effects of interferon-γ and granulocyte colony-stimulating factor on antifungal activity of human polymorphonuclear neutrophils against Candida albicans grown as biofilms or planktonic cells | Q45261277 | ||
| Fluconazole Resistant Candida auris is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses | Q46257698 | ||
| The Candida auris Alert: Facts and Perspectives | Q49489254 | ||
| Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model. | Q49823075 | ||
| Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris. | Q51782762 | ||
| Five-year profile of candidemia at an Indian Trauma Center: high rates of Candida auris blood stream infections. | Q54218129 | ||
| The first isolate of Candida auris in China: clinical and biological aspects. | Q55312173 | ||
| A Candida auris Outbreak and Its Control in an Intensive Care Setting | Q57029894 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| parasitology | Q180502 | ||
| Candida auris | Q26816853 | ||
| emerging pathogen | Q108429945 | ||
| P304 | page(s) | e1007638 | |
| P577 | publication date | 2019-04-08 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | Candida auris: An emerging pathogen "incognito"? | |
| P478 | volume | 15 |
| Q92859506 | Candida auris Biofilm Colonization on Skin Niche Conditions |
| Q89510130 | Candida auris, an Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind? |
| Q92932769 | Improved efficacy of antifungal drugs in combination with monoterpene phenols against Candida auris |
| Q92142505 | Isolation of Candida auris from cystic fibrosis patient, Greece, April 2019 |
| Q94554889 | Repurposing approach identifies pitavastatin as a potent azole chemosensitizing agent effective against azole-resistant Candida species |
| Q98771335 | The Postbiotic Activity of Lactobacillus paracasei 28.4 Against Candida auris |
Search more.